PATENT CLAIM ANALYSIS

Application Number: 15967641
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "173100"]

Abstract:
Provided herein are methods of treatment of Amyotrophic Lateral Sclerosis comprising administration of adrenocorticotropic hormone (ACTH), or fragment, analog, complex or aggregate thereof, or any combination thereof, to an individual in need thereof.

Claim (Index 1):
A method of treating an individual diagnosed with, suspected of having, or predisposed to Amyotrophic Lateral Sclerosis (ALS), comprising administering to the individual an adrenocorticotropic hormone (ACTH) peptide, fragment, or combination thereof, wherein the ACTH peptide, fragment, combination thereof, is administered as a first dose and one or more subsequent doses, and wherein the one or more subsequent doses is from about 20% to about 80% of the first dose.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 93.0
- Lexical Diversity: 1.32258
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13281175', '14214449', '11666485', '15383969', '11007772']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7469939762625991
- 35 USC 102 Novelty (BERT): 0.5565819288414509
- Combined Prediction Score: 0.7279527715204843
- Mean Citation Score: 372.430372
- Max Citation Score: 481.09973
- Similarity Product: 372.03582251400354

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test